A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne Tablets

NCT03196531 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Loratadine (Xisimin [Test Treatment])
DRUG: Loratadine (Clarityne [Reference Treatment])

Sponsor

Xian-Janssen Pharmaceutical Ltd.